Pyridam Farma Tbk PT
IDX:PYFA

Watchlist Manager
Pyridam Farma Tbk PT Logo
Pyridam Farma Tbk PT
IDX:PYFA
Watchlist
Price: 206 IDR -2.83%
Market Cap: 2.3T IDR

Intrinsic Value

The intrinsic value of one PYFA stock under the Base Case scenario is 191.95 IDR. Compared to the current market price of 206 IDR, Pyridam Farma Tbk PT is Overvalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PYFA Intrinsic Value
191.95 IDR
Overvaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Pyridam Farma Tbk PT

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
PYFA
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for PYFA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Pyridam Farma Tbk PT
IDX:PYFA
ID
Pharmaceuticals
Market Cap
2.3T IDR
IPO
Oct 16, 2001
ID
Pharmaceuticals
Market Cap
2.3T IDR
IPO
Oct 16, 2001
Price
Rpfalse
EPS
Rpfalse
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Pyridam Farma Tbk PT
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pyridam Farma Tbk PT

Current Assets 1.5T
Cash & Short-Term Investments 353.5B
Receivables 653B
Other Current Assets 530.6B
Non-Current Assets 4.3T
Long-Term Investments 77B
PP&E 1.5T
Intangibles 2.6T
Other Non-Current Assets 78.1B
Efficiency

Free Cash Flow Analysis
Pyridam Farma Tbk PT

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Pyridam Farma Tbk PT

Revenue
1.9T IDR
Cost of Revenue
-1.4T IDR
Gross Profit
536.5B IDR
Operating Expenses
-646.2B IDR
Operating Income
-109.7B IDR
Other Expenses
-220.5B IDR
Net Income
-330.2B IDR
Fundamental Scores

PYFA Profitability Score
Profitability Due Diligence

Pyridam Farma Tbk PT's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional 1-Year Revenue Growth
Positive 3-Year Average ROE
46/100
Profitability
Score

Pyridam Farma Tbk PT's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

PYFA Solvency Score
Solvency Due Diligence

Pyridam Farma Tbk PT's solvency score is 21/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
High D/E
Positive Net Debt
21/100
Solvency
Score

Pyridam Farma Tbk PT's solvency score is 21/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PYFA Price Targets Summary
Pyridam Farma Tbk PT

There are no price targets for PYFA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PYFA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one PYFA stock?

The intrinsic value of one PYFA stock under the Base Case scenario is 191.95 IDR.

Is PYFA stock undervalued or overvalued?

Compared to the current market price of 206 IDR, Pyridam Farma Tbk PT is Overvalued by 7%.

Back to Top